Numinus Wellness (CVE: NUMI) CEO Payton Nyquvest joined Steve Darling from Proactive to share news the company has agreed to acquire the Neurology Centre of Toronto. The idea would be to develop it into a comprehensive clinical neurology treatment centre with a unique specialization in the application of psychedelics.
Nyquvest telling Proactive Numinus gets the fully operational neurology centre with 13 doctors, 8 allied health staff, nurse practitioners and physician assistants.
Nyquvest also saying they plan to establish the first centre for excellence in psychedelic neurology, with an understanding of how psychedelics can safely and positively impact patients with neurologic illnesses and mental health challenges.